Susan M. Harrington

PD-L1 Expression in Triple-Negative Breast Cancer

Elizabeth A. Mittendorf, Anne V. Philips, Funda Meric‐Bernstam et al. · Cancer Immunology Research · 2014 · 1.4K citations · Full text

Medicine, Molecular Biology, Oncology +17

PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression

Haidong Tang, Yong Liang, Robert A. Anders et al. · Journal of Clinical Investigation · 2018 · 532 citations · Full text

Life Sciences, Immunology, Oncology +17

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)

Neil Mehta, Ankur Kalra, Amy S. Nowacki et al. · JAMA Cardiology · 2020 · 421 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

PD-1 Restrains Radiotherapy-Induced Abscopal Effect

Sean S. Park, Haidong Dong, Xin Liu et al. · Cancer Immunology Research · 2015 · 386 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer

Aaron S. Mansfield, MC Aubry, Justin C. Moser et al. · Annals of Oncology · 2016 · 336 citations · Full text

Medicine, Oncology, Pathology +17